|
|
||||||||
Clinical Chemistry, Vol 16, 139-143, Copyright © 1970 by the American Association for Clinical Chemistry
1 Clinical Chemistry Laboratory, Hartford Hospital,
Hartford, Conn. 06115.
Lithium concentrations in the serum of patients undergoing therapy with lithium salts were measured by atomic absorption spectroscopy. Serum was diluted 10-fold with water. Physiological amounts of sodium and potassium were included in the blank and standard solutions because these cations enhance the lithium signal by 2%. Calcium, magnesium, bicarbonate, sulfate, and phosphate at the concentrations found in serum were without effect. Protein clogging of the triple-slot Boling burner was not observed. The relative standard deviation of within-run variability was 0.6% (n = 20 and x = 0.88 mEq/liter), and of daily precision, tested over a month, it was 2.5% (n = 30, x = 0.91 mEq/liter). Recovery of 1.00 mEq of lithium added per liter of serum ranged from 97 to 103%, averaging 99.8%.
Submitted on December 8, 1969
The following articles in journals at HighWire Press have cited this article:
![]() |
R. Rej Clinical Chemistry through Clinical Chemistry: A Journal Timeline Clin. Chem., December 1, 2004; 50(12): 2415 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. PETERSE, J. M. HAVENAAR, and H. J.M. VAN RIJN Possible Hazard in Use of Priming Dose to Determine Lithium Dosage Am J Psychiatry, January 1, 1999; 156(1): 157a - 158. [Full Text] |
||||
![]() |
T. Rygnestad, K. Aarstad, K. Gustafsson, and U. Jenssen The Clinical Value of Drug Analyses in Deliberate Self-Poisoning Human and Experimental Toxicology, January 1, 1990; 9(4): 221 - 230. [Abstract] [PDF] |
||||
![]() |
T. Rygnestad A Comparative Prospective Study of Self-poisoned Patients in Trondheim, Norway between 1978 and 1987: Epidemiology and Clinical Data Human and Experimental Toxicology, November 1, 1989; 8(6): 475 - 482. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |